Thank you.
Clearly what they say is that, after a careful gap analysis, what was glaringly missing in terms of expertise on the council—because we do have experts in public health, experts in global health, experts in basic research, experts in applied research, and experts in health policy—were experts in commercialization, innovation, and development of pharmacology. So I think we are filling a gap that was identified by council members, and I must say that, unanimously, members of council have approved of the nomination and thanked the government for listening to their request to provide someone who could fill that gap.